72769-101 : Orladeyo 150 mg Oral Capsule


NDC: 72769-101
Labeler: Biocryst Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Orladeyo
Dosage Form: Oral Capsule
Application #: NDA214094
Rev. Date: 


NDC Package Codes:

  • 72769-101-01: 4 DOSE PACK IN 1 CARTON (72769‑101‑01) > 1 BLISTER PACK IN 1 DOSE PACK > 7 CAPSULE IN 1 BLISTER PACK

Active Ingredients:

  • Berotralstat Hydrochloride

Dosage Strength:

  • 150 mg

Pharmaceutical Classes:

  • Cytochrome P450 2D6 Inhibitors [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Kallikrein Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]
  • Plasma Kallikrein Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 72769-102 Orladeyo 110 mg Oral Capsule by Biocryst Pharmaceuticals Inc.
  • 72769-111 Orladeyo 72 mg Oral Pellet by Biocryst Pharmaceuticals, Inc.
  • 72769-112 Orladeyo 96 mg Oral Pellet by Biocryst Pharmaceuticals, Inc.
  • 72769-113 Orladeyo 108 mg Oral Pellet by Biocryst Pharmaceuticals, Inc.
  • 72769-114 Orladeyo 132 mg Oral Pellet by Biocryst Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 72769-101 QR Code

< Prev: 72768-7010Next: 72769-102 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.